Compellingly high SARS-CoV-2 susceptibility of Golden Syrian hamsters suggests multiple zoonotic infections of pet hamsters during the COVID-19 pandemic.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
05 Sep 2022
05 Sep 2022
Historique:
received:
28
05
2022
accepted:
25
08
2022
entrez:
6
9
2022
pubmed:
7
9
2022
medline:
9
9
2022
Statut:
epublish
Résumé
Golden Syrian hamsters (Mesocricetus auratus) are used as a research model for severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2). Millions of Golden Syrian hamsters are also kept as pets in close contact to humans. To determine the minimum infective dose (MID) for assessing the zoonotic transmission risk, and to define the optimal infection dose for experimental studies, we orotracheally inoculated hamsters with SARS-CoV-2 doses from 1 * 10
Identifiants
pubmed: 36064749
doi: 10.1038/s41598-022-19222-4
pii: 10.1038/s41598-022-19222-4
pmc: PMC9442591
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
15069Informations de copyright
© 2022. The Author(s).
Références
mBio. 2022 Feb 1;:e0304421
pubmed: 35100870
Cell Rep. 2020 Dec 8;33(10):108488
pubmed: 33271063
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Lancet. 2022 Mar 12;399(10329):1070-1078
pubmed: 35279259
EBioMedicine. 2022 May;79:103997
pubmed: 35405385
Emerg Microbes Infect. 2020 Dec;9(1):2673-2684
pubmed: 33251966
Lancet Microbe. 2020 Sep;1(5):e218-e225
pubmed: 32838346
Viruses. 2021 Dec 03;13(12):
pubmed: 34960695
Transbound Emerg Dis. 2021 Jul;68(4):1779-1785
pubmed: 33191578
Viruses. 2021 Dec 21;14(1):
pubmed: 35062212
Antiviral Res. 2022 Feb;198:105253
pubmed: 35066015
Epidemiol Infect. 2021 May 14;149:e116
pubmed: 33985614
Lab Invest. 2018 Jul;98(7):844-855
pubmed: 29849125
Int J Infect Dis. 2021 Mar;104:708-710
pubmed: 33548553
Clin Infect Dis. 2020 Dec 3;71(9):2428-2446
pubmed: 32215622
Transbound Emerg Dis. 2021 May;68(3):1075-1079
pubmed: 32946664
Sci Rep. 2021 Mar 23;11(1):6652
pubmed: 33758241
Emerg Microbes Infect. 2022 Dec;11(1):689-698
pubmed: 35135441
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
PLoS Pathog. 2021 Jul 15;17(7):e1009705
pubmed: 34265022
Infect Dis Poverty. 2021 Sep 17;10(1):119
pubmed: 34535192
Lancet. 2022 Mar 12;399(10329):1027-1028
pubmed: 35279247
Nature. 2020 Jul;583(7818):834-838
pubmed: 32408338
Nat Commun. 2020 Nov 27;11(1):6059
pubmed: 33247099
EBioMedicine. 2021 Nov;73:103675
pubmed: 34758415
Med (N Y). 2022 Apr 8;3(4):262-268.e4
pubmed: 35313451
Sci Rep. 2018 Aug 30;8(1):13108
pubmed: 30166611
Vet Pathol. 2022 Jul;59(4):528-545
pubmed: 34856819
Viruses. 2021 Sep 05;13(9):
pubmed: 34578354
Nat Commun. 2021 Jun 30;12(1):4048
pubmed: 34193869
NPJ Vaccines. 2021 Dec 3;6(1):145
pubmed: 34862398
Viruses. 2021 Nov 09;13(11):
pubmed: 34835057
J Infect Dis. 2022 Jan 5;225(1):34-41
pubmed: 34758086